Brian E. Mcdowell

Array ( [id] => 9345080 [patent_doc_number] => 08664228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => '3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases' [patent_app_type] => utility [patent_app_number] => 12/990905 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16514 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186596 [patent_doc_number] => 20110124661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'OXAZOLOBENZIMIDAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/992439 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22056 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124661.pdf [firstpage_image] =>[orig_patent_app_number] => 12992439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368547 [patent_doc_number] => 20090306106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'FORMS OF CRYSTALLINE LAPATINIB AND PROCESSES FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/437518 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2457 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306106.pdf [firstpage_image] =>[orig_patent_app_number] => 12437518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496625 [patent_doc_number] => 08735439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same' [patent_app_type] => utility [patent_app_number] => 12/594186 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 12417 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601815 [patent_doc_number] => 20100048891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'METASUBSTITUTED THIAZOLIDINONES, THEIR MANUFACTURE AND USE AS A DRUG' [patent_app_type] => utility [patent_app_number] => 12/432213 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 93963 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048891.pdf [firstpage_image] =>[orig_patent_app_number] => 12432213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725572 [patent_doc_number] => 08404688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture' [patent_app_type] => utility [patent_app_number] => 12/937405 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 6585 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5457827 [patent_doc_number] => 20090257979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Novel Inhibitors of Hepatitis C Virus Replication' [patent_app_type] => utility [patent_app_number] => 12/423720 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62582 [patent_no_of_claims] => 166 [patent_no_of_ind_claims] => 98 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20090257979.pdf [firstpage_image] =>[orig_patent_app_number] => 12423720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846324 [patent_doc_number] => 08455506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Quinazoline based EGFR inhibitors containing a zinc binding moiety' [patent_app_type] => utility [patent_app_number] => 12/423577 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 19 [patent_no_of_words] => 41934 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12423577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570342 [patent_doc_number] => 20090253720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'ANTIFOLATE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/419739 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24565 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253720.pdf [firstpage_image] =>[orig_patent_app_number] => 12419739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570341 [patent_doc_number] => 20090253719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'CRYSTALLINE SALT FORMS OF ANTIFOLATE COMPOUNDS AND METHODS OF MANUFACTURING THEREOF' [patent_app_type] => utility [patent_app_number] => 12/419732 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17082 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253719.pdf [firstpage_image] =>[orig_patent_app_number] => 12419732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485272 [patent_doc_number] => 20090275037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'FLUORESCENT DOUBLE STRANDED DNA BINDING DYES' [patent_app_type] => utility [patent_app_number] => 12/417735 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9223 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275037.pdf [firstpage_image] =>[orig_patent_app_number] => 12417735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190153 [patent_doc_number] => 20110172437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Perfluorophthalocyanine Molecules and Methods of Synthesis' [patent_app_type] => utility [patent_app_number] => 12/935670 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4874 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172437.pdf [firstpage_image] =>[orig_patent_app_number] => 12935670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055928 [patent_doc_number] => 20110112288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides' [patent_app_type] => utility [patent_app_number] => 12/935309 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12314 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112288.pdf [firstpage_image] =>[orig_patent_app_number] => 12935309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5557777 [patent_doc_number] => 20090269354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/413510 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15931 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269354.pdf [firstpage_image] =>[orig_patent_app_number] => 12413510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026244 [patent_doc_number] => 20110053951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METHODS FOR TREATING DISORDERS USING NMDA NR2B-SUBTYPE SELECTIVE ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/919804 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5430 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053951.pdf [firstpage_image] =>[orig_patent_app_number] => 12919804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149921 [patent_doc_number] => 20110021516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'MONOCYCLIC CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/934208 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39110 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021516.pdf [firstpage_image] =>[orig_patent_app_number] => 12934208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071515 [patent_doc_number] => 20110046366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'LIQUID PORPHYRIN DERIVATIVE, AND METHOD FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/921205 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20132 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046366.pdf [firstpage_image] =>[orig_patent_app_number] => 12921205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421825 [patent_doc_number] => 08278313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Macrocyclic spiro pyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 12/401385 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29039 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12401385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5966382 [patent_doc_number] => 20110149393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof' [patent_app_type] => utility [patent_app_number] => 12/921094 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7731 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20110149393.pdf [firstpage_image] =>[orig_patent_app_number] => 12921094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539762 [patent_doc_number] => 20090221567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF 177' [patent_app_type] => utility [patent_app_number] => 12/392219 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39410 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221567.pdf [firstpage_image] =>[orig_patent_app_number] => 12392219 [rel_patent_id] =>[rel_patent_doc_number] =>)